Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Cited by (1,002)

Items 401–500 of 1,002

1. Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis
   Hiromitsu Ito, Shinji Tanaka, Yoshimitsu Akiyama, Shu Shimada, Rama Adikrisna, Satoshi Matsumura, Arihiro Aihara, Yusuke Mitsunori, Daisuke Ban, Takanori Ochiai et al. · 2016 · PLoS ONE
2. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems
   Frederike Dijk, Veronique L. Veenstra, Eline C. Soer, Mark P.G. Dings, Lan Zhao, Johannes B.G. Halfwerk, Gerrit K. J. Hooijer, Helene Damhofer, Marco Marzano, Anne Steins et al. · 2020 · Scientific Reports
3. Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
   Christian Hirt, Tijmen H. Booij, Linda Grob, Patrik Simmler, Nora C. Toussaint, David Keller, Doreen Taube, Vanessa Ludwig, Alexander Goryachkin, Chantal Pauli et al. · 2022 · Cell Genomics
4. Somatic Point Mutation Calling in Low Cellularity Tumors
   Karin S. Kassahn, Oliver Holmes, Kátia Nones, Ann‐Marie Patch, David K. Miller, Angelika N. Christ, Ivon Harliwong, Timothy J. C. Bruxner, Qinying Xu, Matthew J. Anderson et al. · 2013 · PLoS ONE
5. CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
   Karol A. Szlachta, Cem Kuscu, Turan Tufan, Sara J. Adair, Stephen Shang, Alex D. Michaels, Matthew G. Mullen, Natasha Lopes Fischer, Jiekun Yang, Limin Liu et al. · 2018 · Nature Communications
6. Statin Use and Risk of Pancreatic Cancer
   Yun Zhang, Mingming Liang, Chenyu Sun, Guangbo Qu, Tingting Shi, Min Min, Yile Wu, Yehuan Sun · 2019 · Pancreas
7. Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer
   Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Enrique Gómez‐Gómez, Antonio J. León‐González, Prudencio Sáez-Martínez, Emilia Alors‐Pérez, Antonio C. Fuentes-Fayos, Ana Martínez-López, Rafael Sánchez‐Sánchez, Teresa González-Serrano et al. · 2019 · Translational research
8. Advances in pancreatic cancer research: Moving towards early detection
   Xiangyi He · 2014 · World Journal of Gastroenterology
9. RAS in pancreatic cancer
   Simone Lanfredini, Asmita Thapa, Eric E. O’Neill · 2019 · Biochemical Society Transactions
10. Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer
    Yunguang Li, Shijie Tang, Xiaohan Shi, Jingwen Lv, Xueyuan Wu, Yehan Zhang, Huan Wang, Juan He, Yiqin Zhu, Yi Ju et al. · 2023 · Cell Reports Medicine
11. Digestive cancers: mechanisms, therapeutics and management
    Tianzuo Zhan, Johannes Betge, Nadine Schulte, Lena Dreikhausen, Michael Hirth, Moying Li, Philip Weidner, Antonia Leipertz, Andreas Teufel, Matthias P A Ebert · 2025 · Signal Transduction and Targeted Therapy
12. Plac8 Links Oncogenic Mutations to Regulation of Autophagy and Is Critical to Pancreatic Cancer Progression
    Conan Grant Kinsey, Vijaya Balakrishnan, Michael R. O’Dell, Jing Li Huang, Laurel A. Newman, Christa L. Whitney‐Miller, Aram F. Hezel, Hartmut Land · 2014 · Cell Reports
13. A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer
    Roland Rad, Lena Rad, Wei Ting Wang, Alexander Strong, Hannes Ponstingl, Iraad F. Bronner, Matthew Mayho, Katja Steiger, Julia Weber, Maren Hieber et al. · 2014 · Nature Genetics
14. Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer
    Yunlong Hu, Mingzhou Guo · 2020 · Cancer Science
15. Perineural Invasion and Associated Pain Transmission in Pancreatic Cancer
    Jialun Wang, Yu Chen, Xihan Li, Xiaoping Zou · 2021 · Cancers
16. Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples
    Stefan Graw, Richard L. Meier, Kay T. Minn, Clark Bloomer, Andrew K. Godwin, Brooke L. Fridley, Anda Vlad, Peter Beyerlein, JEREMY R. CHIEN · 2015 · Scientific Reports
17. Inactivating Mutations in SWI/SNF Chromatin Remodeling Genes in Human Cancer
    Takahiro Oike, Hideaki Ogiwara, Takashi Nakano, Jun Yokota, Takashi Kohno · 2013 · Japanese Journal of Clinical Oncology
18. Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth
    Nicola Rath, June Munro, Marie F.A. Cutiongco, Alicja Jagiełło, Nikolaj Gadegaard, Lynn McGarry, Mathieu Unbekandt, Evdokia Michalopoulou, Jurre J. Kamphorst, David P. Sumpton et al. · 2018 · Cancer Research
19. The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas
    Ruth Nussinov, Serena Muratcioğlu, Chung‐Jung Tsai, Hyunbum Jang, Attila Gürsoy, Özlem Keskin · 2015 · Molecular Cancer Research
20. Splice variants as novel targets in pancreatic ductal adenocarcinoma
    Jun Wang, Laurent Dumartin, Andrea Mafficini, Pinar Ulug, Ajanthah Sangaralingam, Namaa Audi Alamiry, Tomasz P. Radon, Roberto Salvia, Rita T. Lawlor, Nicholas Robert Lemoine et al. · 2017 · Scientific Reports
21. Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications
    Sandrina Martens, Pierre Lefesvre, Rémy Nicolle, Andrew Victor Biankin, Francesco Puleo, Jean‐Luc Van Laethem, Ilse Rooman · 2019 · Annals of Oncology
22. Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.
    Xu Zhang, Si Shi, Bo Zhang, Quanxing Ni, Xianjun Yu, Jin Xu · 2018 · PubMed Central
23. Nerve input to tumours: Pathophysiological consequences of a dynamic relationship
    Charlotte Hutchings, Jade A. Phillips, Mustafa B.A. Djamgoz · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
24. CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
    Sara Costa-Cabral, Rachel Brough, Asha Konde, Marieke Aarts, James Campbell, Eliana Marinari, Jenna L. Riffell, Alberto Bardelli, Christopher J. Torrance, Christopher J. Lord et al. · 2016 · PLoS ONE
25. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer
    Kalisz, Mark, Bernardo, Edgar, Beucher, Anthony, Maestro, Miguel Angel, del Pozo, Natalia, Millán, Irene, Haeberle, Lena, Schlensog, Martin, Safi, Sami Alexander, Knoefel, Wolfram Trudo et al. · 2020 · The EMBO Journal
26. Genetic Progression of Pancreatic Cancer
    Robert W. Cowan, Anirban Maitra · 2014 · The Cancer Journal
27. Pathological and Molecular Evaluation of Pancreatic Neoplasms
    Arvind Rishi, Michael Goggins, Laura DeLong Wood, Ralph H. Hruban · 2014 · Seminars in Oncology
28. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis
    Matteo Giulietti, Giulia Occhipinti, Giovanni Principato, Francesco Piva · 2017 · Cellular Oncology
29. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma
    Tamara Gall, Samuel C. Belete, Esha Khanderia, Adam Enver Frampton, Long R. Jiao · 2018 · American Journal Of Pathology
30. Emerging roles of the MAGE protein family in stress response pathways
    Rebecca R. Florke Gee, Helen Chen, Anna K. Lee, Christina A. Daly, Benjamin A. Wilander, Klementina Fon Tacer, Patrick Ryan Potts · 2020 · Journal of Biological Chemistry
31. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas
    Stephanie Downs‐Canner, Mazen S. Zenati, Brian A. Boone, Patrick R. Varley, Jennifer Steve, Melissa Ellen Hogg, Amer H. Zureikat, Herbert J. Zeh, Kenneth K.W. Lee · 2015 · Journal of Surgical Oncology
32. Targeting splicing abnormalities in cancer
    Anant A. Agrawal, Lihua Yu, Peter G. Smith, Silvia Buonamici · 2017 · Current Opinion in Genetics & Development
33. Recessive truncating NALCN mutation in infantile neuroaxonal dystrophy with facial dysmorphism
    Çiğdem Köroğlu, Mehmet Seven, Aslıhan Tolun · 2013 · Journal of Medical Genetics
34. Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
    Caitlin A. McIntyre, Sharon Lawrence, Allison L. Richards, Joanne F. Chou, Winston Wong, Marinela Capanu, Michael F. Berger, Mark T.A. Donoghue, Kenneth H. Yu, Anna M. Varghese et al. · 2020 · Cancer
35. Drugging All RAS Isoforms With One Pocket
    Dirk Kessler, Andreas Bergner, Jark Böttcher, Gerhard Fischer, Sandra Döbel, Melanie Hinkel, Barbara Müllauer, Alexander Weiss-Puxbaum, Darryl B. McConnell · 2020 · Future Medicinal Chemistry
36. SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing
    Qing Tang, Susana Rodriguez-Santiago, Jing Wang, Jia Pu, Andrea Yuste, Varun Gupta, Alberto Moldón, Yong‐Zhen Xu, Charles C. Query · 2016 · Genes & Development
37. Intraductal Oncocytic Papillary Neoplasms
    Tao Wang, Gökçe Aşkan, Volkan N. Adsay, Peter J. Allen, William R. Jarnagin, Bahar Memiş, Carlie Sigel, İpek Erbarut Seven, David S. Klimstra, Olca Baştürk · 2019 · The American Journal of Surgical Pathology
38. Therapeutics Targeting Mutant KRAS
    Kyaw Zin Thein, Amadeo B. Biter, David S. Hong · 2020 · Annual Review of Medicine
39. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma
    Virginia Giuliani, Meredith A. Miller, Chiu-Yi Liu, Stella R. Hartono, Caleb A. Class, Christopher Aaron Bristow, Érika Suzuki, Lionel A. Sanz, Guang Gao, Jason P. Gay et al. · 2021 · Nature Communications
40. Coherence between Cellular Responses and in Vitro Splicing Inhibition for the Anti-tumor Drug Pladienolide B and Its Analogs
    Kerstin A. Effenberger, David D. Anderson, Walter M. Bray, Beth E. Prichard, Nianchun Ma, Matthew S. Adams, Arun Kumar Ghosh, Melissa S. Jurica · 2013 · Journal of Biological Chemistry
41. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis
    Lidong Wang, Huibin Yang, Ethan V. Abel, Gina M. Ney, Phillip Lee Palmbos, Filip Bednar, Yaqing Zhang, Jacob Leflein, Meghna Waghray, Scott R. Owens et al. · 2015 · Genes & Development
42. Combined Targeting of STAT3/NF-κB/COX-2/EP4 for Effective Management of Pancreatic Cancer
    Jingjing Gong, Jianping Xie, Roble G. Bedolla, Paul Rivas, Divya Chakravarthy, James W. Freeman, Robert Lee Reddick, Scott Kopetz, Amanda Peterson, Huamin Wang et al. · 2014 · Clinical Cancer Research
43. ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications
    Samantha Ann Armstrong, Christopher William Schultz, Ariana Azimi-Sadjadi, Jonathan Robert Brody, Michael Jon Pishvaian · 2019 · Molecular Cancer Therapeutics
44. A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity
    Danielle L. Swaney, Dana J. Ramms, Zhiyong Wang, Jisoo Park, Yusuke Goto, Margaret Soucheray, Neil E. Bhola, Kyumin Kim, Fan Zheng, Yan Zeng et al. · 2021 · Science
45. MLL3 loss drives metastasis by promoting a hybrid epithelial–mesenchymal transition state
    Jihong Cui, Chi Zhang, Ji‐Eun Lee, Boris Bartholdy, Dapeng Yang, Yu Liu, Piril Erler, Phillip M. Galbo, Dayle Q. Hodge, Danwei Huangfu et al. · 2023 · Nature Cell Biology
46. mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer
    David R. Driscoll, Saadia A. Karim, Makoto Sano, David Michael Gay, Wright Jacob, Jun Qing Yu, Yusuke Mizukami, Aarthi Gopinathan, Duncan Ian Jodrell, Thomas R. Jeffry Evans et al. · 2016 · Cancer Research
47. Progress in the Treatment of Metastatic Pancreatic Cancer and the Search for Next Opportunities
    Andrew H. Ko · 2015 · Journal of Clinical Oncology
48. Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?
    Irit Ben‐Aharon, Moshe Elkabets, Raphael A. Pelossof, Kenneth H. Yu, Christine A. Iacobuzio–Donahue, Steven D. Leach, Maeve Aine Lowery, Karyn A. Goodman, Eileen Mary O'Reilly · 2019 · Clinical Cancer Research
49. Obesity and Pancreatic Cancer: Insight into Mechanisms
    Guido Eibl, Enrique Rozengurt · 2021 · Cancers
50. Pancreatic adenocarcinoma pathology: changing "landscape".
    Lodewijk A.A. Brosens, Wenzel M. Hackeng, G. Johan A. Offerhaus, Ralph H. Hruban, Laura DeLong Wood · 2015 · Europe PMC (PubMed Central)
51. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy
    Katayoon Kasaian, Sam M. Wiseman, BLAIR A. M. WALKER, Jacqueline E. Schein, Yongjun Zhao, Martin Hirst, Richard A. Moore, Andrew J. J. Mungall, Marco A. Marra, Steven J.M. Jones · 2015 · BMC Cancer
52. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma
    Aaron M. Udager, Jonathan Brad McHugh, Bryan L. Betz, Kathleen T. Montone, Virginia A. LiVolsi, Raja R. Seethala, Evgeny Yakirevich, Obiajulu Hans Iwenofu, Bayardo Perez‐Ordoñez, Kathleen E. DuRoss et al. · 2016 · The Journal of Pathology
53. Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways
    Sanchari Bhattacharyya, Kith Pradhan, Nathaniel R. Campbell, Jozef Mazdo, Aparna Vasantkumar, Shahina Bano Maqbool, Tushar Damodar Bhagat, Sonal Gupta, Masako Suzuki, Yiting Yu et al. · 2017 · Genome Research
54. Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic
    Emmanouil Fokas, Eric O’Neill, Alex Nicolas Gordon-Weeks, Somnath Mukherjee, W. Gillies McKenna, Ruth J. Muschel · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
55. The pancreatic cancer microenvironment: A true double agent
    Laleh Golkar Melstrom, Marcela d'Alincourt Salazar, Don J. Diamond · 2017 · Journal of Surgical Oncology
56. Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
    Carmine Carbone, Geny Piro, Antonio Agostini, Pietro Delfino, Francesco De Sanctis, Vincenzo Nasca, Francesco Spallotta, Claudio Sette, Maurizio Martini, Stefano Ugel et al. · 2021 · Journal for ImmunoTherapy of Cancer
57. Recent advances in the ARID family: focusing on roles in human cancer
    Hong Zhao, Song Wei, Xinyu Bi, Jianjun Zhao, Zhen Kun Huang, Zhiyu Li, Jian‐Guo Zhou, Jianqiang Cai, Lin Chen · 2014 · OncoTargets and Therapy
58. The lymphatic system and pancreatic cancer
    Darci M. Fink, Maria M. Steele, Michael Anthony Hollingsworth · 2015 · Cancer Letters
59. Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities
    Venessa T. Chin, Adnan M. Nagrial, Angela S. Y. Chou, Andrew Victor Biankin, Anthony James Gill, Paul Timpson, Marina Pajic · 2015 · Expert Reviews in Molecular Medicine
60. Potent effects of dioscin against pancreatic cancer via miR‐149‐3P‐mediated inhibition of the Akt1 signalling pathway
    Lingling Si, Lina Xu, Lianhong Yin, Yan Qi, Xu Han, Youwei Xu, Yanyan Zhao, Kexin Liu, Jinyong Peng · 2017 · British Journal of Pharmacology
61. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy
    Daniela Laura Papademetrio, Silvina Laura Lompardía, Tania Simunovich, Susana N. Costantino, Cintia Mihalez, Victoria Cavaliere, Elida E. Alvarez · 2015 · Targeted Oncology
62. Deciphering the role of hedgehog signaling in pancreatic cancer
    Dongsheng Gu, E Kelly, Jingwu Xie · 2016 · Journal of Biomedical Research
63. Personalized cancer vaccines: Targeting the cancer mutanome
    Xiuli Zhang, Piyush Kumar Sharma, Simon Peter Goedegebuure, William E. Gillanders · 2016 · Vaccine
64. Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors
    Matthew S. Dietz, Thomas Lee Sutton, Brett S. Walker, Charles E. Gast, Luai R. Zarour, Sidharth K. Sengupta, John R. Swain, Jennifer R. Eng, Michael S. Parappilly, Kristen E. Limbach et al. · 2021 · Scientific Reports
65. SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer
    Gregory P. Botta, Shumei Kato, Hitendra Patel, Paul Timothy Fanta, Suzanna Lee, Ryosuke Okamura, Razelle Kurzrock · 2021 · JCI Insight
66. Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes
    Michael James Thompson, Liudmilla Rubbi, David W. Dawson, Timothy R. Donahue, Matteo A. Pellegrini · 2015 · PLoS ONE
67. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics
    Sarah Munchel, Yen Nguyen Thi Hoang, Yue Zhao, Joseph Cottrell, Brandy Klotzle, Andrew K. Godwin, Devin C. Koestler, Peter Beyerlein, Jian‐Bing Fan, Marina V. Bibikova et al. · 2015 · Oncotarget
68. Pancreatic tumours escape from translational control through 4E-BP1 loss
    Yvan Martineau, R Azar, D Müller, Charline Lasfargues, Sally El Khawand, Rodica Anesia, Jerry Pelletier, Corinne Bousquet, Stéphane Pyronnet · 2013 · Oncogene
69. Sirtuin-1 Regulates Acinar-to-Ductal Metaplasia and Supports Cancer Cell Viability in Pancreatic Cancer
    Elke Wauters, Victor Javier Sanchez-Arevalo Lobo, Andreia V. Pinho, Amanda Mawson, Daniel Herranz, Jianmin Wu, Mark J. Cowley, Emily K. Colvin, Erna Ngwayi Njicop, Rob L. Sutherland et al. · 2013 · Cancer Research
70. Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability
    Jäkel, Cornelia, Bergmann, Frank, Toth, Reka, Assenov, Yassen, van der Duin, Daniel, Strobel, Oliver, Hank, Thomas, Klöppel, Günter, Dorrell, Craig, Grompe, Markus et al. · 2017 · Nature Communications
71. Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation
    William Brian Dalton, Eric Helmenstine, Noel Walsh, Lukasz P. Gondek, Dhanashree S. Kelkar, Abigail Read, Rachael Natrajan, Eric Scott Christenson, Bárbara Román, Samarjit Das et al. · 2019 · Journal of Clinical Investigation
72. Cryo-EM structure of the human MLL1 core complex bound to the nucleosome
    Sang Ho Park, Alex M. Ayoub, Young‐Tae Lee, Jing Xu, Hanseong Kim, Wei Hui Zheng, Biao Zhang, Sha Liang, Sojin An, Yang Zhang et al. · 2019 · Nature Communications
73. Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
    Raffaella Casolino, Chiara Braconi, Giuseppe Malleo, Salvatore Paiella, Claudio Bassi, Michèle Milella, Stephan B. Dreyer, Fieke E. M. Froeling, David Kuang-Fu Chang, Andrew Victor Biankin et al. · 2020 · Annals of Oncology
74. The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer
    Kimura, Hirokazu, Klein, Alison P., Hruban, Ralph H., Roberts, Nicholas J. · 2021 · Pancreas
75. Comparing somatic mutation-callers: beyond Venn diagrams
    Su Yeon Kim, Terence Paul Speed · 2013 · BMC Bioinformatics
76. Genetics and Biology of Pancreatic Ductal Adenocarcinoma
    Richard Francis Dunne, Aram F. Hezel · 2015 · Hematology/Oncology Clinics of North America
77. Splicing and cancer: Challenges and opportunities
    Patrícia P. Coltri, Maria Gabriela Pereira dos Santos, Gleyce Kelly Silva · 2019 · Wiley Interdisciplinary Reviews - RNA
78. Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve
    Noelle R. Jurcak, Lei Zheng · 2019 · Pharmacology & Therapeutics
79. Recent advances in the treatment of pancreatic cancer
    Marc T Roth, Dana Backlund Cardin, Jordan D. Berlin · 2020 · F1000Research
80. Fruit-derived phenolic compounds and pancreatic cancer: Perspectives from Australian native fruits
    Quan V. Vuong, Sathira Hirun, Phoebe A. Phillips, Tiffany L.K. Chuen, Michael Christian Bowyer, Chloé Goldsmith, Christopher James Scarlett · 2014 · Journal of Ethnopharmacology
81. Acquired Mutations That Affect Pre-mRNA Splicing in Hematologic Malignancies and Solid Tumors
    Latanya M. Scott, Vivienne I. Rebel · 2013 · JNCI Journal of the National Cancer Institute
82. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling
    Zhibo Xie, Yifan Zhang, Chen Jin, Yishen Mao, Deliang Fu · 2019 · Journal of Experimental & Clinical Cancer Research
83. Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy
    Ramot, Yuval, Rotkopf, Shay, Gabai, Rachel Malka, Zorde Khvalevsky, Elina, Muravnik, Sofia, Marzoli, Gabriela Alejandra, Domb, Abraham J., Shemi, Amotz, Nyska, Abraham · 2016 · Toxicologic Pathology
84. Precision Oncology in Surgery
    Stephan B. Dreyer, Mark Pinese, Nigel Balfour Jamieson, Christopher James Scarlett, Emily K. Colvin, Marina Pajic, Amber L. Johns, Jeremy L. Humphris, Jianmin Wu, Mark J. Cowley et al. · 2018 · Annals of Surgery
85. Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer
    Mariano Ponz‐Sarvisé, Vincenzo Corbo, Hervé Tiriac, Dannielle D. Engle, Kristopher K. Frese, Tobiloba E. Oni, Chang‐Il Hwang, Daniel Öhlund, Iok In Christine Chio, Lindsey A. Baker et al. · 2019 · Clinical Cancer Research
86. Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
    Cheng‐Cao Sun, Youqiong Ye, Zhi Tan, Yuan Liu, Yajuan Li, Wei Hu, Ke Liang, Sergey D. Egranov, Lisa A. Huang, Zhao Zhang et al. · 2023 · Science Advances
87. Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures
    Jermaine L. Jenkins, Clara L. Kielkopf · 2017 · Trends in Genetics
88. CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
    Tu, Q, Hao, J, Zhou, X, Yan, L, Dai, H, Sun, B, Yang, D, An, S, Lv, L, Jiao, B et al. · 2018 · Oncogene
89. Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancer
    Erik S. Knudsen, Vishnu Muthuraj Kumarasamy, Amanda Ruiz, Jared Sivinski, Sejin Chung, Adam D. Grant, Paris J. Vail, Shailender Singh Chauhan, Tun Jie, Taylor Sohn Riall et al. · 2019 · Oncogene
90. Improving outcomes of patients with pancreatic cancer
    Stephan B. Dreyer, Philip A. Beer, Sunil R. Hingorani, Andrew Victor Biankin · 2025 · Nature Reviews Clinical Oncology
91. Transposon mutagenesis identifies genetic drivers of BrafV600E melanoma
    Michael B. Mann, Michael A. Black, Devin J. Jones, Jerrold Michael Ward, Christopher Chin Kuan Yew, Justin Y. Newberg, Adam J. Dupuy, Alistair G. Rust, Marcus Bosenberg, Martin McMahon et al. · 2015 · Nature Genetics
92. Clinical and pathologic features of familial pancreatic cancer
    Jeremy L. Humphris, Amber L. Johns, Skye H. Simpson, Mark J. Cowley, Marina Pajic, David Kuang-Fu Chang, Adnan M. Nagrial, Venessa T. Chin, Lorraine A. Chantrill, Mark Pinese et al. · 2014 · Cancer
93. Mitochondrial mutations and metabolic adaptation in pancreatic cancer
    Australian Pancreatic Cancer Genome Initiative, Rae‐Anne Hardie, Ellen van Dam, Mark J. Cowley, Ting-Li Han, Seher Balaban, Marina Pajic, Mark Pinese, Mary Iconomou, Robert F. Shearer et al. · 2017 · Cancer & Metabolism
94. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer
    Seetharaman Balasenthil, Ying Huang, Suyu Liu, Tracey L. Marsh, Jinyun Chen, Sanford A. Stass, Debra L. Kukuruga, Randall E. Brand, Nanyue Chen, Marsha L. Frazier et al. · 2017 · JNCI Journal of the National Cancer Institute
95. Molecular Events in the Natural History of Pancreatic Cancer
    Leslie E. Oldfield, Ashton Anthony Connor, Steve Gallinger · 2017 · Trends in cancer
96. Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms
    Michael Francis Skaro, Neha Nanda, Christian D. Gauthier, Matthäus Felsenstein, Zhengdong Jiang, Miao‐Zhen Qiu, Koji Shindo, Jun Yu, Danielle Hutchings, Ammar A. Javed et al. · 2019 · Gastroenterology
97. Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer
    Chandan Kanta Das, Indranil Banerjee, Mahitosh Mandal · 2019 · Seminars in Cancer Biology
98. NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes
    Ömer An, Vera Pendino, Matteo D’Antonio, Emanuele Ratti, Marco Gentilini, Francesca D. Ciccarelli · 2014 · Database
99. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
    Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel · 2020 · Cancers
100. Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes
     Anna M. Varghese, Isha Singh, Ritu Singh, Siddharth Kunte, Joanne F. Chou, Marinela Capanu, Winston Wong, Maeve Aine Lowery, Zsofia Kinga Stadler, Erin E. Salo‐Mullen et al. · 2021 · JNCI Journal of the National Cancer Institute